HIF1A and neoplasm: The HIF-1 inhibitory activity of melatonin and NB-5-MT has been confirmed to significantly inhibit angiogenesis, epithelial-mesenchymal transition (EMT), and tumor growth in various mouse models with xenografted tumors of breast, prostate, and kidney cancer cells [62,65,66].